BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36394528)

  • 1. Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restriction.
    Andres F; Hannan NJ; Walker SP; MacDonald TM; Wong GP; Murphy C; Cannon P; Kandel M; Masci J; Nguyen TV; Abboud A; Idzes D; Kyritsis V; Pritchard N; Tong S; Kaitu'u-Lino TJ
    FASEB J; 2022 Dec; 36(12):e22651. PubMed ID: 36394528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
    Sci Rep; 2021 Oct; 11(1):20670. PubMed ID: 34667209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Circulating and Placental SPINT2 Is Associated with Placental Dysfunction.
    Murphy CN; Walker SP; MacDonald TM; Keenan E; Hannan NJ; Wlodek ME; Myers J; Briffa JF; Romano T; Roddy Mitchell A; Whigham CA; Cannon P; Nguyen TV; Kandel M; Pritchard N; Tong S; Kaitu'u-Lino TJ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
    Pregnancy Hypertens; 2021 Aug; 25():255-261. PubMed ID: 34325289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia.
    Gibbs I; Leavey K; Benton SJ; Grynspan D; Bainbridge SA; Cox BJ
    Am J Obstet Gynecol; 2019 Jan; 220(1):110.e1-110.e21. PubMed ID: 30312585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
    Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of EPCR in plasma and placenta of patients with early onset severe preeclampsia].
    Zhu JM; He M; Huang L; Su YL; Li L; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):678-682. PubMed ID: 27671049
    [No Abstract]   [Full Text] [Related]  

  • 11. Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor.
    von Versen-Höynck F; Rajakumar A; Bainbridge SA; Gallaher MJ; Roberts JM; Powers RW
    Placenta; 2009 May; 30(5):434-42. PubMed ID: 19303140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.
    Bloise E; Zhang J; Nakpu J; Hamada H; Dunk CE; Li S; Imperio GE; Nadeem L; Kibschull M; Lye P; Matthews SG; Lye SJ
    Am J Obstet Gynecol; 2021 Mar; 224(3):298.e1-298.e8. PubMed ID: 32853537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of lateral placenta on preeclampsia and small for gestational age neonates: a systematic review and meta-analysis.
    Siargkas A; Tsakiridis I; Grammenos P; Apostolopoulou A; Giouleka S; Mamopoulos A; Athanasiadis A; Dagklis T
    J Perinat Med; 2023 May; 51(4):468-476. PubMed ID: 36174088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.
    de Alwis N; Beard S; Binder NK; Pritchard N; Tong S; Kaitu'u-Lino TJ; Hannan NJ
    Pregnancy Hypertens; 2022 Dec; 30():13-20. PubMed ID: 35933758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurora kinase mRNA expression is reduced with increasing gestational age and in severe early onset fetal growth restriction.
    Beard S; Pritchard N; Binder N; Schindler K; De Alwis N; Kaitu'u-Lino TJ; Tong S; Hannan NJ
    Placenta; 2020 Jun; 95():53-61. PubMed ID: 32452402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom K; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Hui L; Tong S; Hannan NJ
    Sci Rep; 2021 Mar; 11(1):5540. PubMed ID: 33692394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.